Loading company…
Shenzhen Burui develops breath-analysis systems for disease screening and diagnosis.
Founded in 2019, Shenzhen Burui develops hardware and AI software for analyzing volatile organic compounds in exhaled breath. Its Scents A-3 mass spectrometer monitors compounds in real time, and the company has worked with hospitals on research involving tuberculosis, lung cancer, and esophageal cancer. Based in Shenzhen, China, its Hunan production base passed GMP certification in January 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in